King Abdullah International Research Centre
Jeddah, Saudi Arabia
NCT Number: NCT06595550
Cross over randomized design for adding whey protein to Suhoor meal for patients with T1DM during fasting Ramadan
Looking for future studies?
Notify Me14 year–70 year
All sexes
Interventional
Not applicable
Jeddah, Saudi Arabia
Patients with type1 diabetes who intend to fast will be supplied with dietary supplement "Whey protein" to be taken with Suhoor (predawn meal) for one week during Ramadan. They will be then crossed over to not taking the whey protein for another week. the order of taking whey protein will be randomized.
During both weeks patients will be monitored through flash continuous glucose monitoring and data will be compared in regards to incidence and timing of hypoglycemia, hyperglycemia, and time in target range.
After Ramadan data will be collected on number of days they had to brake fast due to low blood sugar during both weeks and overall satisfaction with using whey protein during Ramadan.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Powder milk
Powder milk
Time frame: 1 month
number of hypoglycemic events (blood glucose <70mg/dl) as detected by flash glucose monitoring
Time frame: 1 month
Glucose profiles as detected by flash glucose monitoring
Time frame: 1 month
glucose parameters detected by flash glucose monitoring by and lab
Time frame: 1 month
number of days fast broken during each week
Time frame: 1 month
to compare patient satisfaction
King Abdullah International Medical Research Center
Other
The Effect of Whey Protein Consumption on Hypoglycemia in Adults with Type 1 Diabetes During the Fasting Holy Month of Ramadan: a Randomized, Crossover Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05536232
Autoimmune Diseases, Diabetes Mellitus
Paris, France
View Trial DetailsNCT05766657
Autoimmune Diseases, Body Weight
Milan, Milano, Italy
View Trial DetailsNCT06408558
Type1 Diabetes
Guildford, Surrey, United Kingdom
View Trial DetailsNCT04520971
Type1 Diabetes
Aalst, Oost-Vlaanderen, Belgium
View Trial Details